Featured Research

from universities, journals, and other organizations

University Of Pittsburgh Researcher Identifies Serum Sex Hormones As Powerful Predictors Of Breast Cancer

Date:
February 17, 1999
Source:
University Of Pittsburgh Medical Center
Summary:
Results of a study published in the February 16 issue of the Annals of Internal Medicine suggest that in the near future a simple blood test to detect levels of sex hormones could predict which women are at the highest risk of developing breast cancer. With this information, physicians could determine who would be good candidates for medications that can reduce the risk of the disease.

PITTSBURGH, Feb. 15 -- Results of a study published in the February 16 issue of the Annals of Internal Medicine suggest that in the near future a simple blood test to detect levels of sex hormones could predict which women are at the highest risk of developing breast cancer. With this information, physicians could determine who would be good candidates for medications that can reduce the risk of the disease. Jane A. Cauley, Dr.P.H., associate professor of epidemiology at the University of Pittsburgh's Graduate School of Public Health (GSPH), led the multi-center, federally funded study.

Related Articles


"In our study of older women, we found those with the highest levels of either serum estradiol or testosterone were three times more likely than expected to develop breast cancer," said Dr. Cauley. "This magnitude of risk is much higher than that observed for other breast cancer risk factors."

She explained, "Each year more than 180,000 women are diagnosed with breast cancer in the United States. Although well-established risk factors exist for breast cancer, more than 90 percent of all women have at least one of these factors and, individually, each factor only modestly increases a woman's risk of developing the disease."

The research involved participants from the Study of Osteoporotic Fractures and included 97 women who developed breast cancer and 244 randomly selected controls. All women were white, 65 years of age or older and not receiving estrogen. The estimated incidence of breast cancer was lowest (4 per 10,000 women/year) in women with the lowest blood levels of estradiol and testosterone. Conversely, the incidence of breast cancer was highest (65 per 10,000 women/year) in women with the highest concentrations of both hormones.

This research strengthens previous reports indicating that hormone levels influence the risk of breast cancer, according to Dr. Cauley. "This type of information could help clinicians direct high-risk women to consider chemoprevention for breast cancer," said Dr. Cauley. "Results from the Breast Cancer Prevention Trial and the Multiple Outcomes of Raloxifene Evaluation Trial have shown that certain medications can reduce the incidence of breast cancer."

Unlike previous reports, results of this study showed that testosterone and estradiol independently contributed to breast cancer risk. For many years, researchers have known that estradiol, a metabolic product of estrogen, fuels the growth of some breast cancers. The way that testosterone may contribute to breast cancer growth is unclear at this time, according to Dr. Cauley.

Studies are currently underway to determine whether selective estrogen receptor modifiers, or SERMS, can reduce the incidence of breast cancer in women who have high baseline measurements of estradiol. In addition, studies like the Women's Health Trial have shown that dietary modifications can reduce blood levels of estradiol in post-menopausal women. In another study, the Women's Health Initiative, investigators are waiting to see whether reduced dietary fat will translate into a decrease in the number of breast cancer cases.

Because absolute levels of hormones in older women are low, the study employed extremely sensitive, accurate assays to measure differences among levels in study participants. These sensitive assays are not yet clinically available, according to Dr. Cauley.

###

For more information on the GSPH department of epidemiology, access the website: http://www.pitt.edu/~epidept/epihome.html.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "University Of Pittsburgh Researcher Identifies Serum Sex Hormones As Powerful Predictors Of Breast Cancer." ScienceDaily. ScienceDaily, 17 February 1999. <www.sciencedaily.com/releases/1999/02/990217080035.htm>.
University Of Pittsburgh Medical Center. (1999, February 17). University Of Pittsburgh Researcher Identifies Serum Sex Hormones As Powerful Predictors Of Breast Cancer. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/1999/02/990217080035.htm
University Of Pittsburgh Medical Center. "University Of Pittsburgh Researcher Identifies Serum Sex Hormones As Powerful Predictors Of Breast Cancer." ScienceDaily. www.sciencedaily.com/releases/1999/02/990217080035.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins